CME Course – Partnering with Patients using lifestyle modification and motivational interviewing – Step 3b in Hypertension Control
|Last Modified||September 21, 2023|
|Audience||Healthcare Professionals ||
|Topics||Measure Accurately ||
|Resource Type||Video / Webinar | Weblink|
Activity has been approved for CME/CE credit
Webinar was recorded: February 23, 2022
This activity trains providers and other care team members registered for the AHA/AMA joint Target: BP™ initiative, on the “Partner with patients, families, and communities” component of the AMA MAP Quality Improvement Framework. The content addresses the evidence base for lifestyle interventions and interpersonal techniques for engaging patients in making lifestyle modifications. The presenters explore collaborative communication and motivational interviewing frameworks, examples, and case scenarios. MAP stands for Measure Accurately, Act Rapidly, and Partner with Patients.
At the completion of this course, the learner will be able to:
- Review the evidence-based nonpharmacological lifestyle interventions to prevent and treat hypertension.
- Describe the approximate impact of specific nonpharmacological lifestyle interventions on systolic blood pressure.
- Outline the role of collaborative communication including motivational interviewing and evidence-based strategies in promoting patient adherence to lifestyle interventions.
- Identify resources that can support clinic staff and patients to learn more about lifestyle interventions.
|22:13||Part 2: Review evidence-based nonpharmacological lifestyle interventions and impact on SBP||Juna Ma|
|15:33||Part 3: Review evidence-based nonpharmacological lifestyle interventions and the role of collaborative communication||Kimberly Ketter|
|14:59||Part 4: Case Scenario||Alison Smith|
Estimated Time to Complete the Educational Activity
Alison Smith, MPH, BA, BSN, RN
Program Director, Target: BP
American Heart Association
June Ma, MD, PhD, FAHA, FABMR, FSBM
Founding Dir., Vitoux Program on Aging & Prevention
Assoc. Head of Research, Dept. of Medicine
University of Illinois Chicago
Kimberly Ketter, AGNP-C, CDE
Adult/Geriatric Nurse Practitioner & Certified Diabetes Educator
Advisory Group Member - National AHA’s Know Diabetes by Heart
ORIGINAL RELEASE DATE: 04/01/2022
TERMINATION DATE: 03/31/2025
Joint Accreditation Statements
In support of improving patient care, this activity has been planned and implemented by the American Heart Association and the American Medical Association. The American Heart Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA Credit Designation Statement - Physicians
The American Heart Association designates this activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA Credit Acceptance Statement – Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 0.75 hours of Category I credit for completing this program.
AANP Credit Acceptance Statement – Nurse Practitioners
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
ANCC Credit Designation Statement - Nurses
The maximum number of hours awarded for this CE activity is 0.75 contact hours.
All persons in a position to control educational content of a CE activity provided by the American Heart Association must disclose to the audience all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The presence or absence of all financial relationships will be disclosed to the audience in activity materials. All unlabeled/unapproved uses of drugs or devices discussed will also be disclosed to the audience. All relevant financial relationships have been mitigated prior to the commencement of the activity.